Project Grant R01AG093516
Award Date 9/1/26
Completion Date 6/30/29
Dollars Obligated $634K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
- The National Institute on Aging awarded The Johns Hopkins University $769,960 under the Aging Research program (CFDA 93.866) on September 1, 2026, for research examining how changes in home health care agency ownership and private capital investment affect access to care, quality of care, and patient outcomes for people living with dementia. The project, which runs through May 31, 2031, investigates the impact of multi-state chain acquisitions and private capital investments on home health...
- The National Institute on Aging awarded $526,607 to Wake Forest University on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop computational imaging frameworks that integrate neuroimaging with multi-omics data to identify Alzheimer's disease subtypes and model neurodegenerative progression with calibrated uncertainty. The project, titled "Neuroimaging Multi-Omics Fingerprints for Subtyping and Uncertainty-Aware Prediction of Alzheimer's Disease," will...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $2,373,964 will fund a 3-year study examining the use of telehealth to improve care for long-stay nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to: 1) qualitatively assess how telehealth is used in nursing homes and barriers/facilitators to its adoption, 2) characterize telehealth and in-person care utilization patterns for this population...
- The National Institute on Aging awarded Duke University $1.597 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to support research on epitranscriptomic regulation of microglia in Alzheimer's disease. The research investigates how m6a methylation of adenosine residues in messenger RNA regulates microglial cell function and transitions between resting and activated states during Alzheimer's disease pathogenesis, with the goal of identifying novel...
- The National Institute on Aging awarded the University of Alabama at Birmingham $5,057,416 on September 15, 2025, under the Aging Research program (CFDA 93.866) to examine the impact of undiagnosed dementia on healthcare utilization across geographic regions. The recipient will augment Medicare claims data with cognitive assessment data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a longitudinal cohort of 30,239 participants from 1,833 counties across the...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The University of California, Los Angeles received a $2.7 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion scheduled for August 31, 2029. This research project will generate rigorous evidence comparing health outcomes for older patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) who are discharged from hospitals to home-based care versus facility-based...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded Duke University $493,972 on January 1, 2026, under the Aging Research program (CFDA 93.866) to investigate cell type-specific epitranscriptomic regulation in the brain during aging and Alzheimer's disease. The research will determine how age-dependent differential methylation of adenosine (M6A) in distinct brain cell types influences the expression of genes associated with Alzheimer's disease. The...
- The National Institute on Aging awarded Duke University $3.272 million under the Aging Research program (CFDA 93.866) on August 5, 2026, to conduct a five-year comparative study examining whether switching Medicaid waiver beneficiaries from paid aides to paid family members for home care increases time at home and reduces publicly funded healthcare costs. The research, conducted in Durham, North Carolina, uses North Carolina Medicaid program data from 2017–2025 to apply causal inference...
- The National Institute on Aging awarded the University of Virginia $583,815 on August 15, 2026, under the Aging Research program (CFDA 93.866) to support research into oligodendrocyte lineage dysfunction during aging and Alzheimer's disease. The project aims to understand how myelin loss—a pathology common to both aging and Alzheimer's disease—develops in the central nervous system and to identify therapeutic targets for cognitive impairment. The research focuses on oligodendrocyte precursor...